Year archive

RENALYTIX PLC — 2020 filings

All 44 regulatory filings released by RENALYTIX PLC (RENX) in 2020, sourced directly from the official regulator.

44 Filings

2020 Period

2020 filings (44)

Filing	Released	Lang
Result of AGM Declaration of Voting Results & Voting Rights Announcements	2020-12-07	English
Partnership with National Kidney Foundation Regulatory Filings	2020-12-02	English
Holding(s) in Company Major Shareholding Notification	2020-11-26	English
Second Price Monitoring Extn Regulatory Filings	2020-11-25	English
Price Monitoring Extension Regulatory Filings	2020-11-25	English
Financial Results for First Quarter of FY 2021 Earnings Release Q1 2021	2020-11-25	English
Stifel 2020 Healthcare Conference Regulatory Filings	2020-11-13	English
Change of Adviser Regulatory Filings	2020-11-06	English
Posting of Annual Report & Accounts &Notice of AGM Report Publication Announcement	2020-11-02	English
Full Year Report Audit Report / Information FY 2020	2020-10-27	English
Notice of Results Report Publication Announcement	2020-10-16	English
Verici Dx - Intention to admit to trading on AIM Capital/Financing Update	2020-10-13	English
California Commercial Lab Certification Recieved Regulatory Filings	2020-09-22	English
KidneyIntelX clinical testing launch Regulatory Filings	2020-09-18	English
Grant of Purchase Rights and Verici update Regulatory Filings	2020-09-02	English
Submission seeking FDA Clearance of KidneyIntelX Regulatory Filings	2020-08-26	English
RenalytixAI to Collaborate with AstraZeneca Regulatory Filings	2020-08-21	English
KidneyIntelX in Multi-Center Study Regulatory Filings	2020-08-03	English
Total Voting Rights Regulatory Filings	2020-07-31	English
Over allotment option exercise Capital/Financing Update	2020-07-27	English
Closing of Global Offering and resulting TVR Regulatory Filings	2020-07-21	English
Pricing of Global Offering Regulatory Filings	2020-07-17	English
Launch of Global Offering and application to list Capital/Financing Update	2020-07-13	English
Result of General Meeting Declaration of Voting Results & Voting Rights Announcements	2020-07-13	English
Approval of distribution of shares in Verici Dx Regulatory Filings	2020-07-08	English
Partnership with America’s Choice Provider Network Regulatory Filings	2020-07-08	English
Holding(s) in Company Major Shareholding Notification	2020-07-07	English
KidneyIntelX study accepted for publication Regulatory Filings	2020-07-01	English
University of Michigan Partnership & Data Sharing Regulatory Filings	2020-06-30	English
Proposed Board changes; Circular & Notice of GM Regulatory Filings	2020-06-25	English
Public filing re. Nasdaq dual-listing and offering Regulatory Filings	2020-06-25	English
KidneyIntelX™ receives New York State approval Regulatory Filings	2020-06-12	English
Confirmation of reduction of capital Regulatory Filings	2020-06-10	English
Positive results of clinical validation study Regulatory Filings	2020-06-10	English
Second Price Monitoring Extn Regulatory Filings	2020-05-20	English
Price Monitoring Extension Regulatory Filings	2020-05-20	English
JV for COVID-19 antibody test scaled production Regulatory Filings	2020-05-20	English
Proposed dual-listing on Nasdaq Capital/Financing Update	2020-05-18	English
Result of General Meeting Declaration of Voting Results & Voting Rights Announcements	2020-05-15	English
Removal of US Securities Law Restrictions Regulatory Filings	2020-05-05	English
Update re. potential demerger of FractalDx Regulatory Filings	2020-04-28	English
Utah Lab Facility Achieves ISO 13485 Certification Regulatory Filings	2020-04-27	English
KidneyIntelX used in Mount Sinai COVID-19 study Regulatory Filings	2020-04-20	English
Provider network agreement for KidneyIntelX™ Regulatory Filings	2020-04-15	English